Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gonyautoxin 2/3 for Acute Back Pain
NCT04799041Phase 2Completed
- Sponsor
- Algenis
- Start
- Oct 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gonyautoxin 2 + gonyautoxin 3 in acute low back pain, sponsored by Algenis. Started Oct 2019; status: completed.
02
Drugs
gonyautoxin 2 + gonyautoxin 3
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT04799041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04799041.